Osteoarthritis Management, August 2023 through June 2024
| Aspiration Volume, cc | Percentage Change From Previous Appointment | ||||
|---|---|---|---|---|---|
| Date | Left Knee | Right Knee | Left Knee | Right Knee | Injections/Approvals/Procedures |
| August 10, 2023 | 16.5 | 37 | – | – | Bilateral intra-articular Kenalog injections |
| September 12, 2023 | – | – | – | – | Insurance approval for iovera° (Pacira BioSciences, Inc) submitted |
| October 26, 2023 | – | – | – | – | Approved for iovera° Because of greater pain in left knee, left superficial genicular nerves treated with iovera° |
| November 20, 2023 | 17 | 14 | +3.0 | –62.2 | Unchanged left knee pain Bilateral intra-articular knee Kenalog injections iovera° treatment in the left knee |
| December 19, 2023 | 27 | 41 | +58.8 | +192.9 | Bilateral intra-articular knee Monovisc injections iovera° treatment in the left knee |
| March 19, 2024 | 27 | 42 | +0.0 | +2.4 | Bilateral intra-articular knee Zilretta injections |
| May 23, 2024 | 2 | 5 | –92.6 | –88.1 | Bilateral intra-articular Monovisc injections |
| June 19, 2024 | 0 | 0 | –100 | –100 | Bilateral intra-articular Zilretta injections |
Note: All aspiration and injection procedures were performed under ultrasound guidance.